Clinical Trial Update: A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of MDT-637 in adults with intermittent or mild-to-moderate persistent asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MDT-637

Snippet

Sponsor: MicroDose Therapeutx, Inc | Conditions: Drug Safety | Phase 1 | Status: COMPLETED